Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Extension CombiRx data show no benefit of combined MS drugs
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models.
Treatment of multiple sclerosis with the pregnancy hormone estriol.
Incorporating Alcohol Pharmacotherapies Into Medical Practice
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Genzyme reports positive top-line results of TOWER, a pivotal phase III trial for AUBAGIO(TM*) (teriflunomide) in relapsing multiple sclerosis
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
Neuropathology of white matter disease in Leber's hereditary optic neuropathy.
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.
Immune competence after alemtuzumab treatment of multiple sclerosis.
Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
A Pilot Trial of Interferon beta-1a in Alzheimer's Disease
Autoimmune Hepatitis-like reaction developing in a patient treated with Interferon beta 1a.
New analysis shows Novartis drug Gilenya® significantly reduced rate of brain volume loss across three large Phase III studies
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial.
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
A much-needed focus on progression in multiple sclerosis.
NICE recommends new treatment option for multiple sclerosis (Dimethyl fumarate)
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
Gene expression analysis reveals functional pathways of glatiramer acetate activation.
A G protein-coupled receptor is essential for Schwann cells to initiate myelination.
Antioxidant properties of the triaminopyridine, flupirtine.
Pages
« first
‹ previous
…
59
60
61
62
63
64
65
66
67
…
next ›
last »